Clinical Trial: Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Multicentric, Randomized, Open-label Trial to Evaluate the Superiority of Fixed Dose Combination of Oxomemazine, Guaifenesin and Potassium Iodate to Guaifenesin Monotherapy in Acute STUDY DESIGN
- Open-label, superiority, prospective, parallel group, intent to treat trial
- Experiment duration: 7 days
- 3 visits (days 1, 2 and 7)
- Reduction cough symptoms
- Adverse events evaluation
Sponsor: EMS
Current Primary Outcome: Reduction/improvement of cough symptoms [ Time Frame: DAY 7 ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Tolerance [ Time Frame: DAY 7 ]
Original Secondary Outcome: Same as current
Information By: EMS
Dates:
Date Received: December 8, 2010
Date Started: February 2013
Date Completion: September 2013
Last Updated: February 26, 2013
Last Verified: February 2013